DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury
Clinical trial NCT07567274 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07567274
- Sponsor
- Leading Edge Clinic
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-15
- Primary completion
- 2026-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.